These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication. Bose D; Deb Adhikary N; Xiao P; Rogers KA; Ferrell DE; Cheng-Mayer C; Chang TL; Villinger F J Virol; 2024 Feb; 98(2):e0165223. PubMed ID: 38299866 [TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques. Mainou E; Berendam SJ; Obregon-Perko V; Uffman EA; Phan CT; Shaw GM; Bar KJ; Kumar MR; Fray EJ; Siliciano JM; Siliciano RF; Silvestri G; Permar SR; Fouda GG; McCarthy J; Chahroudi A; Conway JM; Chan C Epidemics; 2024 Sep; 48():100780. PubMed ID: 38964130 [TBL] [Abstract][Full Text] [Related]
8. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption. Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173 [TBL] [Abstract][Full Text] [Related]
9. Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model. Goswami R; Nelson AN; Tu JJ; Dennis M; Feng L; Kumar A; Mangold J; Mangan RJ; Mattingly C; Curtis AD; Obregon-Perko V; Mavigner M; Pollara J; Shaw GM; Bar KJ; Chahroudi A; De Paris K; Chan C; Van Rompay KKA; Permar SR mBio; 2019 Sep; 10(5):. PubMed ID: 31488511 [TBL] [Abstract][Full Text] [Related]
10. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection. Long S; Fennessey CM; Newman L; Reid C; O'Brien SP; Li Y; Del Prete GQ; Lifson JD; Gorelick RJ; Keele BF J Virol; 2019 Dec; 94(1):. PubMed ID: 31597776 [TBL] [Abstract][Full Text] [Related]
12. Conformation of HIV-1 Envelope Governs Rhesus CD4 Usage and Simian-Human Immunodeficiency Virus Replication. Vilmen G; Smith AC; Benet HC; Shukla RK; Larue RC; Herschhorn A; Sharma A mBio; 2022 Feb; 13(1):e0275221. PubMed ID: 35012342 [TBL] [Abstract][Full Text] [Related]
13. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422 [TBL] [Abstract][Full Text] [Related]
14. Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques. Bauer A; Lindemuth E; Marino FE; Krause R; Joy J; Docken SS; Mallick S; McCormick K; Holt C; Georgiev I; Felber B; Keele BF; Veazey R; Davenport MP; Li H; Shaw GM; Bar KJ PLoS Pathog; 2023 Jul; 19(7):e1011059. PubMed ID: 37399208 [TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies. Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691 [TBL] [Abstract][Full Text] [Related]
17. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques. Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus. Ho O; Larsen K; Polacino P; Li Y; Anderson D; Song R; Ruprecht RM; Hu SL Retrovirology; 2009 Jul; 6():65. PubMed ID: 19602283 [TBL] [Abstract][Full Text] [Related]
19. Early antibody therapy can induce long-lasting immunity to SHIV. Nishimura Y; Gautam R; Chun TW; Sadjadpour R; Foulds KE; Shingai M; Klein F; Gazumyan A; Golijanin J; Donaldson M; Donau OK; Plishka RJ; Buckler-White A; Seaman MS; Lifson JD; Koup RA; Fauci AS; Nussenzweig MC; Martin MA Nature; 2017 Mar; 543(7646):559-563. PubMed ID: 28289286 [TBL] [Abstract][Full Text] [Related]
20. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. Bolton DL; Pegu A; Wang K; McGinnis K; Nason M; Foulds K; Letukas V; Schmidt SD; Chen X; Todd JP; Lifson JD; Rao S; Michael NL; Robb ML; Mascola JR; Koup RA J Virol; 2016 Feb; 90(3):1321-32. PubMed ID: 26581981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]